CGX-1007

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2011
01220022011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Glutamate induced excitotoxic injury through over-activation of N-methyl-D-aspartate receptors (NMDARs) plays a critical role in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2005
2005
The potent NMDA receptor antagonist, Conantokin-G (CGX-1007), a snail peptide, has an 8-h therapeutic window in rat focal… (More)
Is this relevant?
2004
2004
The N-methyl-D-aspartate (NMDA) receptor-gated ion channel is comprised of at least one NR1 subunit and any of four NR2 subunits… (More)
Is this relevant?
2004
2004
CGX-1007, a 17-amino acid polypeptide isolated from the venom of Conus geographus, is a novel NMDA receptor antagonist that is… (More)
Is this relevant?
2003
2003
Delayed cell death following ischemic brain injury has been linked to alterations in gene expression. In this study we have… (More)
  • table 1
  • figure 1
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
2003
2003
While the role of apoptosis in neuronal injury is continually being re-defined, approaches to intervene in the progression of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2003
2003
  • Uniformed Servicces
  • 2003
Conantokin-G (Con-G or CGX-1007), a potent NR2B subunit selective NMDA receptor antagonist, was evaluated for its neuroprotective… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2002
2002
The NMDA antagonist CGX-1007 (Conantokin-G) has previously been shown to possess potent neuroprotective properties when… (More)
Is this relevant?
Review
2002
Review
2002
Epilepsy is currently the most prevalent neurological disorder worldwide. Pharmacological therapy remains the cornerstone of… (More)
Is this relevant?